Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Dynavax Technologies Corporation, a commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States. It markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. The company also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a collaboration agreement with Valneva Scotland Limited; Zhejiang Clover Biopharmaceuticals, Inc.; Clover Biopharmaceuticals (Hong Kong) Co., Limited; Biological E. Limited; PT Bio Farma; Medigen Vaccine Biologics; and Serum Institute of India Pvt. Ltd. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. The company was incorporated in 1996 and is headquartered in Emeryville, California. more
Time Frame | DVAX | Sector | S&P500 |
---|---|---|---|
1-Week Return | 0.16% | -1.8% | -0.77% |
1-Month Return | -5.49% | -3.48% | 0.71% |
3-Month Return | 18.33% | -7.2% | 8.81% |
6-Month Return | 6.78% | -1.54% | 12.32% |
1-Year Return | -3.73% | 8.39% | 30.57% |
3-Year Return | -2.27% | 6.07% | 29.21% |
5-Year Return | 95.61% | 44.07% | 91.95% |
10-Year Return | -15.07% | 106.3% | 196.04% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 35.22M | 46.55M | 439.44M | 722.68M | 232.28M | [{"date":"2019-12-31","value":4.87,"profit":true},{"date":"2020-12-31","value":6.44,"profit":true},{"date":"2021-12-31","value":60.81,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":32.14,"profit":true}] |
Cost of Revenue | 19.39M | 13.91M | 173.57M | 262.15M | 50.17M | [{"date":"2019-12-31","value":7.4,"profit":true},{"date":"2020-12-31","value":5.31,"profit":true},{"date":"2021-12-31","value":66.21,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":19.14,"profit":true}] |
Gross Profit | 15.83M | 32.64M | 265.87M | 460.53M | 182.12M | [{"date":"2019-12-31","value":3.44,"profit":true},{"date":"2020-12-31","value":7.09,"profit":true},{"date":"2021-12-31","value":57.73,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":39.55,"profit":true}] |
Gross Margin | 44.95% | 70.12% | 60.50% | 63.73% | 78.40% | [{"date":"2019-12-31","value":57.33,"profit":true},{"date":"2020-12-31","value":89.43,"profit":true},{"date":"2021-12-31","value":77.17,"profit":true},{"date":"2022-12-31","value":81.28,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Operating Expenses | 137.32M | 107.86M | 132.38M | 178.01M | 219.15M | [{"date":"2019-12-31","value":62.66,"profit":true},{"date":"2020-12-31","value":49.22,"profit":true},{"date":"2021-12-31","value":60.41,"profit":true},{"date":"2022-12-31","value":81.23,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Operating Income | (121.49M) | (75.22M) | 134.49M | 283.52M | (37.03M) | [{"date":"2019-12-31","value":-42.85,"profit":false},{"date":"2020-12-31","value":-26.53,"profit":false},{"date":"2021-12-31","value":47.43,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-13.06,"profit":false}] |
Total Non-Operating Income/Expense | (44.72M) | (24.67M) | (68.00M) | 11.96M | 52.66M | [{"date":"2019-12-31","value":-84.91,"profit":false},{"date":"2020-12-31","value":-46.85,"profit":false},{"date":"2021-12-31","value":-129.12,"profit":false},{"date":"2022-12-31","value":22.7,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Pre-Tax Income | (152.60M) | (75.24M) | 77.52M | 294.30M | (4.37M) | [{"date":"2019-12-31","value":-51.85,"profit":false},{"date":"2020-12-31","value":-25.57,"profit":false},{"date":"2021-12-31","value":26.34,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-1.48,"profit":false}] |
Income Taxes | (1.20M) | 16.54M | 808.00K | 1.14M | 2.02M | [{"date":"2019-12-31","value":-7.28,"profit":false},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":4.89,"profit":true},{"date":"2022-12-31","value":6.91,"profit":true},{"date":"2023-12-31","value":12.23,"profit":true}] |
Income After Taxes | (151.40M) | (91.78M) | 76.71M | 293.16M | (6.39M) | [{"date":"2019-12-31","value":-51.64,"profit":false},{"date":"2020-12-31","value":-31.31,"profit":false},{"date":"2021-12-31","value":26.17,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-2.18,"profit":false}] |
Income From Continuous Operations | (155.22M) | (82.95M) | 76.71M | 293.16M | 61.12M | [{"date":"2019-12-31","value":-52.95,"profit":false},{"date":"2020-12-31","value":-28.29,"profit":false},{"date":"2021-12-31","value":26.17,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":20.85,"profit":true}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | (151.40M) | (91.78M) | 76.71M | 293.16M | (6.39M) | [{"date":"2019-12-31","value":-51.64,"profit":false},{"date":"2020-12-31","value":-31.31,"profit":false},{"date":"2021-12-31","value":26.17,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-2.18,"profit":false}] |
EPS (Diluted) | (2.08) | (0.84) | 0.34 | 1.97 | (0.06) | [{"date":"2019-12-31","value":-105.58,"profit":false},{"date":"2020-12-31","value":-42.64,"profit":false},{"date":"2021-12-31","value":17.26,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-2.96,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
DVAX | |
---|---|
Cash Ratio | 10.91 |
Current Ratio | 13.23 |
Quick Ratio | 12.34 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
DVAX | |
---|---|
ROA (LTM) | -0.38% |
ROE (LTM) | 3.18% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
DVAX | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.36 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.64 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
DVAX | |
---|---|
Trailing PE | 86.07 |
Forward PE | 49.51 |
P/S (TTM) | 6.51 |
P/B | 2.48 |
Price/FCF | 94 |
EV/R | 4.51 |
EV/Ebitda | 30.20 |
PEG | NM |
Dynavax Technologies Corporation (DVAX) share price today is $12.91
Yes, Indians can buy shares of Dynavax Technologies Corporation (DVAX) on Vested. To buy Dynavax Technologies Corporation from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in DVAX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Dynavax Technologies Corporation (DVAX) via the Vested app. You can start investing in Dynavax Technologies Corporation (DVAX) with a minimum investment of $1.
You can invest in shares of Dynavax Technologies Corporation (DVAX) via Vested in three simple steps:
The 52-week high price of Dynavax Technologies Corporation (DVAX) is $15.01. The 52-week low price of Dynavax Technologies Corporation (DVAX) is $9.74.
The price-to-earnings (P/E) ratio of Dynavax Technologies Corporation (DVAX) is 85.6667
The price-to-book (P/B) ratio of Dynavax Technologies Corporation (DVAX) is 2.48
The dividend yield of Dynavax Technologies Corporation (DVAX) is 0.00%
The market capitalization of Dynavax Technologies Corporation (DVAX) is $1.69B
The stock symbol (or ticker) of Dynavax Technologies Corporation is DVAX